🟢 Edesa Biotech is trading 6.5% up in after-hours trading

Edesa Biotech is trading at $2.96, up 6.47% in after-hours trading; no specific catalyst has been identified.

• Edesa Biotech closed October 19 at $2.78, up 8.17% in the regular session; no new company-specific announcement was identified.
• October 15 FDA clearance to expand the Phase 2 vitiligo study to U.S. sites, with topline data anticipated in Q4 2027, predates the move; its connection is unclear.
• Broad-market indices were higher.